Sunday, 15 November 2026European Markets

ATEA And 3 Other Stocks Have Very High Payout Ratio

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Loading stream...

(vianews) - webstep (wstep.ol), wereldhave belgium (wehb.br), atea (atea.ol) are the highest payout ratio stocks on this list.

here's the data we've collected of stocks with a high payout ratio so far. the payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

when investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. webstep (wstep.ol)

120.57% payout ratio

webstep asa, together with its subsidiaries, provides information technology (it) consultancy services to public and private businesses in norway and sweden. the company offers digitalization, cloud migration and integration, internet of things, machine learning, it security, robotics, and analytics. its services include consulting, digitalization, .net, java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, beacons, enterprise user experience, web analysis, design team, amazon web, azure, prediction, ai, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. the company serves banking, finance and insurance, public administration, agriculture and food production, it and telecommunication, commerce, and transportation industries. the company was founded in 2000 and is headquartered in oslo, norway.

earnings per share

as for profitability, webstep has a trailing twelve months eps of kr1.53.

pe ratio

webstep has a trailing twelve months price to earnings ratio of 14.9. meaning, the purchaser of the share is investing kr14.9 for every norwegian krone of annual earnings.

growth estimates quarters

the company's growth estimates for the ongoing quarter and the next is 74.3% and 125%, respectively.

volume

today's last reported volume for webstep is 7683 which is 28.05% below its average volume of 10679.

more news about webstep.

2. wereldhave belgium (wehb.br)

98.13% payout ratio

wereldhave belgium is a public regulated real estate company with a focus on commercial property in belgium. wereldhave belgium targets its new investments on shopping centres. the value of the real estate portfolio, including project developments, amounted to € 921.2 mln on 31 december 2020. on 31 december 2020 the existing operational retail portfolio amounted to € 817.8 mln (around 90% of the total portfolio) and it includes shopping centres in liège, nivelles, tournai, genk and kortrijk and retail parks in brugge, ghent, turnhout, waterloo and tournai. in addition, the portfolio of real estate investments includes offices in vilvoorde and antwerp. as of 31 december 2020 the development portfolio of € 12.6 mln contained land holdings and realised investments that relate to the refurbishment and/or expansion of shopping centres in waterloo and liège.

earnings per share

as for profitability, wereldhave belgium has a trailing twelve months eps of €4.28.

pe ratio

wereldhave belgium has a trailing twelve months price to earnings ratio of 10.23. meaning, the purchaser of the share is investing €10.23 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.61%.

yearly top and bottom value

wereldhave belgium's stock is valued at €43.80 at 17:10 est, under its 52-week low of €44.00.

volume

today's last reported volume for wereldhave belgium is 178 which is 84.3% below its average volume of 1134.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on apr 17, 2023, the estimated forward annual dividend rate is 4.2 and the estimated forward annual dividend yield is 9.13%.

more news about wereldhave belgium.

3. atea (atea.ol)

76.1% payout ratio

atea asa provides it infrastructure and related solutions for businesses and public sector organizations in the nordic countries and baltic regions. the company offers hardware and software solutions for storing and managing information, as well as tools for virtualization, automation, and security for operating the data center environment; and client hardware, software, and services to the requirements of users, applications, security, networks, and computing environments. it also provides hardware and software solutions for running networks, and services to help customers manage their communications; and a range of products to enable collaboration through conferencing, information sharing, and digital productivity solutions. in addition, it offers digital workplace solutions that consist of devices and software through which users conducts work, access data and applications, and interact with each other; information management solutions; and it asset lifecycle management, professional, and managed services. atea asa was founded in 1968 and is headquartered in oslo, norway.

earnings per share

as for profitability, atea has a trailing twelve months eps of kr7.72.

pe ratio

atea has a trailing twelve months price to earnings ratio of 16.3. meaning, the purchaser of the share is investing kr16.3 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.33%.

more news about atea.

4. bic (bb.pa)

58.72% payout ratio

société bic sa manufactures and sells stationery, lighter, shaver, and other products worldwide. it offers ball and coloring felt pens, gel ink pens, markers, sticky notes, leads, whiteboards, and correction tapes, as well as graphite, coloring, mechanical, and other pencils; reusable notebooks, digital slates, and smart pens; art and craft kits; permanent and temporary tattoo markers; and pen and pencil refills. the company also provides refillable shavers and razors; and pocket, utility, and decorated lighters. in addition, it sells batteries and shaving preps; and advertising and promotional products. further, the company is involved in the provision of delivery services; production of industrial equipment; and manufacture and distribution of it solutions and consumer products, as well as in real estate and insurance activities. it markets its products primarily under the bic, bic kids, cello, lucky, rocketbook, tipp-ex, bic wite-out, tattly, ami, djeep, inkbox, bic soleil, bic evolution, and bodymark brands through a range of channels, including retail mass-market distributors, traditional stores, and office product stationers, as well as an e-commerce site. the company was founded in 1944 and is headquartered in clichy, france.

earnings per share

as for profitability, bic has a trailing twelve months eps of €4.69.

pe ratio

bic has a trailing twelve months price to earnings ratio of 12.52. meaning, the purchaser of the share is investing €12.52 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.44%.

sales growth

bic's sales growth for the next quarter is negative 4.5%.

moving average

bic's worth is under its 50-day moving average of €60.30 and under its 200-day moving average of €58.95.

revenue growth

year-on-year quarterly revenue growth grew by 4.4%, now sitting on 2.28b for the twelve trailing months.

yearly top and bottom value

bic's stock is valued at €58.70 at 17:10 est, way under its 52-week high of €70.60 and way above its 52-week low of €51.15.

more news about bic.

1. 1 (1)

1% payout ratio

1

earnings per share

as for profitability, 1 has a trailing twelve months eps of €1.

pe ratio

1 has a trailing twelve months price to earnings ratio of 1. meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1%.

growth estimates quarters

the company's growth estimates for the present quarter and the next is 1% and 1%, respectively.

volatility

1's last week, last month's, and last quarter's current intraday variation average was 1.00%, 1.00%, and 1.00%.

1's highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

volume

today's last reported volume for 1 is 1 which is 1% above its average volume of 1.

more news about 1.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com